Manual reintegration! [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2008-08-28 14:44 (6138 d 17:36 ago) – Posting: # 2272
Views: 24,138

❝ IMHO, in any case the analytical 'quality' will decrease. The section should be deleted entirely - it's simply stupid.


Hi,

there is actually a relevant parallel in the preclinical standard package and certain types of human pharmacology studies. When (new) drugs are evaluated for the potential to provoke torsades-de-pointes (pardon my French!), it is done by ECG's coupled with software for semi-automated evaluation of the QT-intervals. As far as I know, the ECG software automatically finds/calculates/measures the QT-interval, while a technician goes manually through such data to verify the intervals are reasonably accurately identified. In certain cases (s)he may correct the interval but there is no requirement for printing copies of corrected and uncorrected ECG's, afaik. This is pretty much a similar situation, isn't it? It seems to work well for the ECG's that way. I am not aware of any people dropping dead because the software failed and the corrected and uncorrected QT was not printed.

The software companies might love the idea, though. It would give them an incentive to develop options to scan through audit trails, find chromatograms that have been manually integrated and print them out along with some brainy statistics on the impact of the manual corrections, all in a format suited to the European regulator's eye.

But after all, do thoughts about chromatolophystic integration really belong in the BE-guideline? If European regulators really have something important to say about integration of chromatograms for the bioanalysis for inv. of BE, wouldn't it be relevant to assume they would expect the same standards for PK analyses for other drugs than just the BE ones? If yes, then the whole issues does not belong in the BE guideline.
It would be much more relevant to simply write such things in a separate guideline dealing with bioanalysis in a general perspecitve - such a GL is much wanted anyway. All in all, my solution is:
  1. Re-think the integration issues, possibly get inspiration from ICH E14.
  2. Remove the integration issues from the BE guideline.
  3. Get started on a general bioanalysis guideline and include the thoughts about integration there.
EM.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
37 visitors (0 registered, 37 guests [including 11 identified bots]).
Forum time: 08:20 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5